37
BIOTECHNOLOGY VALUE FUND II LP updates its Form D — $1.41B sold
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $1.41B · SAN FRANCISCO, CA · filed 2025-12-23
3(c)(7) — qualified purchasers
37
BIOTECHNOLOGY VALUE FUND II LP updates its Form D — $1.33B sold
Fund raise update · Hedge fund · Open-ended · SAN FRANCISCO, CA · Form D/A filed 2024-12-27 · all Biotechnology Value vehicles
$100M+ sold3(c)(7) — qualified purchasers
Why now — by persona
Relevant to: Fund audit & tax, Fund administrator. Lead card pending.
People on the filing
| James N. Kratky | Chief Financial Officer, Chief Compliance Officer |
| Mark N. Lampert | Chief Executive Officer |
| n/a BVF Inc. | Executive Officer |
| n/a N. BVF II GP LLC | General Partner |
| n/a BVF Partners, L.P. | Investment Manager |
| Jason N. McCune | Chief Operating Officer |
| n/a N. BVF GP Holdings LLC | Executive Officer |
Signed by Mark N. Lampert, Chief Executive Officer of the General Partner.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.